Company Filing History:
3 out of 3 
3 out of 3 Years Active: 2024-2025
Title: Meiwei Gong: Innovator in Tumor Detection Technologies
Introduction
Meiwei Gong is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical diagnostics, particularly in the detection of tumors. With a total of 3 patents, his work focuses on innovative reagent compositions that enhance the accuracy of tumor detection.
Latest Patents
Meiwei Gong's latest patents include two notable inventions. The first patent is titled "Reagent composition for detection of non-hematopoietic tumor and use thereof." This invention provides a reagent composition that includes three sets of antibodies designed for flow cytometry screening, diagnosis, and follow-up detection of non-hematopoietic tumors. The second patent, "Detection reagent and therapeutic target for B cell tumor after targeted therapy and related application," offers a reagent composition that can be applied for the detection of B-lymphocyte tumors after targeted therapy using flow cytometry.
Career Highlights
Throughout his career, Meiwei Gong has worked with reputable organizations such as Synarc Research Laboratory and Hebei Yanda Ludaopei Hospital. His experience in these institutions has allowed him to develop and refine his innovative approaches to tumor detection.
Collaborations
Meiwei Gong has collaborated with notable professionals in his field, including Hui Wang and Man Chen. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Meiwei Gong's contributions to tumor detection technologies demonstrate his commitment to advancing medical diagnostics. His innovative patents reflect a deep understanding of the complexities involved in tumor detection and treatment.